These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9232539)

  • 1. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats.
    Frussa-Filho R; Abílio VC; Bergamo M; Palermo-Neto J
    J Pharm Pharmacol; 1997 Apr; 49(4):412-5. PubMed ID: 9232539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of melatonin on behavioral dopaminergic supersensitivity.
    Abílio VC; Vera JA; Ferreira LS; Duarte CR; Martins CR; Torres-Leite D; Ribeiro Rde A; Frussa-Filho R
    Life Sci; 2003 May; 72(26):3003-15. PubMed ID: 12706487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats.
    Tieppo CA; Silva AM; Palermo-Neto J; Nasello AG; Felicio LF
    Braz J Med Biol Res; 1995 Mar; 28(3):351-4. PubMed ID: 8520531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice.
    Queiroz CM; Alcântara FB; Yagüe AM; Bibancos T; Frussa-Filho R
    Braz J Med Biol Res; 2002 Feb; 35(2):237-42. PubMed ID: 11847528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of low versus high dose haloperidol treatments on spontaneous and apomorphine induced motor behavior: evidence that at a very low dose haloperidol acts as an indirect dopamine agonist.
    Dias FR; de Matos LW; Sampaio Mde F; Carey RJ; Carrera MP
    Behav Brain Res; 2012 Apr; 229(1):153-9. PubMed ID: 22244923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine.
    Boye SM; Rompré PP
    J Neurosci; 2000 Feb; 20(3):1229-39. PubMed ID: 10648727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effect of apomorphine and haloperidol on MPP neurotoxicity.
    Espinosa-Oliva AM; de Pablos RM; Santiago M
    Pharmacology; 2014; 93(3-4):101-7. PubMed ID: 24556705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):153-64. PubMed ID: 6137027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of single and long-term haloperidol administration on open field behavior of rats.
    Bernardi MM; De Souza H; Palermo Neto J
    Psychopharmacology (Berl); 1981; 73(2):171-5. PubMed ID: 6785810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ovariectomy and of estrogen administration on some dopamine-related behaviors in the rat.
    Dorce VA; Palermo-Neto J
    Braz J Med Biol Res; 1988; 21(2):313-20. PubMed ID: 3203165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.